Position in BMY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,770,892,290
+$241,766,824 QoQ
Shares Held
29,198,554
+3.0% QoQ
Ownership
1.43%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 70.96288398391235.ToString("F0")%
Shared 0.ToString("F0")%
None 29.037116016087644.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $57,054,147,722 across 20 Drug Manufacturers - General names. BMY ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,437,458 | $14,198,910,733 | |
| 2 | JNJ |
Johnson & Johnson
|
44,721,167 | $10,931,642,052 | |
| 3 | ABBV |
AbbVie Inc.
|
38,016,774 | $8,268,268,167 | |
| 4 | MRK |
Merck & Co., Inc.
|
47,632,487 | $5,729,711,852 | |
| 5 | AMGN |
Amgen Inc
|
15,836,058 | $5,571,916,998 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,299,295 | $3,247,222,731 | |
| 7 | PFE |
Pfizer Inc
|
92,685,370 | $2,602,605,180 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
29,198,554 | $1,770,892,290 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,770,892,290 | 29,198,554 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,529,125,466 | 28,348,637 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,256,835,606 | 27,867,752 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,240,928,189 | 26,807,695 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,947,942,153 | 31,938,714 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,716,017,661 | 30,339,775 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,446,578,575 | 27,958,612 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,086,221,498 | 26,155,105 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,587,290,939 | 29,269,610 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,507,563,268 | 29,381,471 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,125,538,376 | 36,621,957 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $2,236,496,671 | 34,972,583 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,311,948,360 | 33,356,635 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,547,905,622 | 35,412,170 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,102,255,347 | 29,571,745 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,785,286,812 | 36,172,556 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,013,141,253 | 27,565,949 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,541,038,230 | 24,715,930 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,484,917,831 | 25,095,789 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,638,108,597 | 24,515,244 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $1,629,430,369 | 25,810,714 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,551,955,175 | 25,019,429 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,275,891,220 | 21,162,568 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,142,669,805 | 19,433,160 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,012,599,369 | 18,166,476 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||